Abstract:Yi Zhang, 1 Xiujin Shi, 1 Jialun Han, 1 Wenxing Peng, 1 Zhenwei Fang, 1 Yang Zhou, 1 Xiaoyu Xu, 1 Jie Lin, 2, 3 Fucheng Xiao, 4 Limin Zhao, 3 Yang Lin 1 1 Department of Pharmacy, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, People's Republic of China; 2 Department of Endocrinology and Metabolism, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, People's Republic of China; 3 Department of Atherosclerosis, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, 100029, People's Republic of China; 4 Department of Cardiovascular Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, People's Republic of China Correspondence: Yang Lin Department of Pharmacy, Beijing Anzhen Hospital, Capital Medical University, No. 2 Anzhen Road, Beijing, 100029, People's Republic of China Tel/Fax +86-10-64456045 Email linyang3623@outlook.com Introduction: As the primary immune cells, macrophages play a key role in atherosclerotic progression. M2 macrophage polarization has been reported to promote tissue repair and attenuate plaque formation upon the expression of anti-inflammatory factors. Convallatoxin (CNT) is a natural cardiac glycoside with anti-inflammatory pharmacological properties. However, whether CNT protects against atherosclerosis (AS) and underlying mechanisms is unknown. This work was designed to explore the potential effects of CNT on atherosclerosis. Methods: In this study, Apolipoprotein E deficiency (ApoE −/- ) mice fed with high-fat diet were established, and CNT (50 or 100 μg/kg) were intragastrically administrated for 12 weeks every day. In vitro, RAW264.7 macrophages stimulated with ox-LDL were treated with CNT (50 or 100 nM) for 24 h. The specific PPARγ antagonist, GW9662, was used to block the PPARγ signaling pathway in vitro. Then, the atherosclerotic lesions, macrophage polarization markers, inflammatory cytokines and PPARγ signaling pathway were examined in further examinations. Results: Our results showed that the atherosclerotic lesions were reduced by CNT, as demonstrated by the downregulation of serum lipid level and aortic plaque area in AS mice. Furthermore, we found that CNT treatment promoted the expression of M2 macrophage markers (Arg1, Mrc1, Retnla and Chi3l3), and decreased the levels of pro-inflammatory cytokines (IL-6 and TNF-α), accompanied by the increase of anti-inflammatory factor (IL-10) in aortic vessels of AS mice. In ox-LDL-induced RAW264.7 cells, CNT administration also facilitated macrophages polarizing towards M2 subtype and inhibited inflammatory responses. Furthermore, both the in vivo and in vitro experiments showed CNT could increase the expression of PPARγ, Integrin α v and Integrin β 5 , and GW9662 could block CNT-induced M2 macrophage polarization. Conclusion: Taken together, these data suggest that CNT may promote M2 macrophage polarization to exert an anti-atherosclerotic effect, partially through activating PPARγ-Integrin α v β 5 signaling pathway. Keywords: atherosclerosis, convallatoxin, macrophage polarization, ox-LDL, PPARγ-Integrin α v β 5 signaling pathway

L-cystathionine Inhibits Oxidized Low Density Lipoprotein-Induced THP-1-derived Macrophage Inflammatory Cytokine Monocyte Chemoattractant Protein-1 Generation Via the NF-κB Pathway

L-cystathionine Protects Against Oxidative Stress and DNA Damage Induced by Oxidized Low-Density Lipoprotein in THP-1-derived Macrophages.

L-cystathionine Inhibits the Mitochondria-Mediated Macrophage Apoptosis Induced by Oxidized Low Density Lipoprotein.

S‐Allyl‐L‐Cysteine Sulfoxide Inhibits Tumor Necrosis Factor‐Alpha Induced Monocyte Adhesion and Intercellular Cell Adhesion Molecule‐1 Expression in Human Umbilical Vein Endothelial Cells

Microrna-181A Represses Ox-Ldl-stimulated Inflammatory Response in Dendritic Cell by Targeting C-Fos

Downregulation of activating transcription factor 4 attenuates lysophosphatidycholine-induced inflammation via the NF-κB pathway.

Tanshinone II-A Inhibited Oxidized Low-Density-Lipoprotein Induced LOX-1 Expression in Murine Macrophages by Reduction of Intracellular Reactive Oxygen Species (ROS) and NF-KappaB Activation

Leukocyte Cell-Derived Chemotaxin 2 Inhibits Development of Atherosclerosis in Mice

P17 Hydrogen sulfide suppresses ox-LDL-stimulatedmonocyte chemoattractant protein-1 generation from macrophages via NF- κ B pathway

7-Ketocholesterol Promotes Cholesterol Uptake and Inflammation in Macrophage: Potential Mechanisms of Dietary COP in Atherosclerosis Promotion

Hydrogen Sulfide Suppresses Oxidized Low-density Lipoprotein (Ox-Ldl)-stimulated Monocyte Chemoattractant Protein 1 Generation from Macrophages Via the Nuclear Factor Κb (Nf-Κb) Pathway*

Oxldl/β2gpi/anti-Β2gpi Complex Induced Macrophage Differentiation to Foam Cell Involving TLR4/NF-kappa B Signal Transduction Pathway

Chondroitin Sulfate Inhibits Monocyte Chemoattractant Protein-1 Release From 3T3-L1 Adipocytes: A New Treatment Opportunity for Obesity-Related Inflammation?

Inhibition of Toll-like Receptors Alters Macrophage Cholesterol Efflux and Foam Cell Formation

Oxidized Low-Density Lipoprotein Loading of Macrophages Downregulates TLR-Induced Proinflammatory Responses in a Gene-Specific and Temporal Manner through Transcriptional Control

Convallatoxin Promotes M2 Macrophage Polarization to Attenuate Atherosclerosis Through PPARγ-Integrin αvβ5 Signaling Pathway

[Effect and mechanism of PCSK9 on lectin-like oxidized low-density lipoprotein receptor-1 mediated oxidized low-density lipoprotein uptake by THP-1 derived macrophages]

Effect of Hydrogen Sulfide Inhibiting Monocyte Chemoattractant Protein-1 Secretion in Human Macrophages Stimulated by Oxidized Low Density Lipoprotein

CXCL4 downregulates the atheroprotective hemoglobin receptor CD163 in human macrophages

Effects of LPS and dietary free fatty acids on MCP-1 in 3T3-L1 adipocytes and macrophages in vitro

Inhibitory Effect of 3-(4-Hydroxyphenyl)-1-(thiophen-2-yl) prop-2-en-1-one, a Chalcone Derivative on MCP-1 Expression in Macrophages via Inhibition of ROS and Akt Signaling